ALTERITY THERAPEUTICS LTD (ATHE)
$4.51-$0.05 (-1.10%) Today
Alterity Therapeutics Ltd is a clinical-stage biotechnology company focused on neurodegenerative diseases and the creation of a chemical library of proprietary molecules. Its research and clinical development efforts are focused on Parkinson's disease and related disorders, where it is identifying and developing novel compounds that address the underlying pathology of these disorders by binding and redistributing excess labile iron, reducing alpha-synuclein aggregation, and rescuing neurons in the brain. Its pipeline programs are ATH434-201, ATH434-202, bioMUSE, ATH434, and Drug Discovery. The Group operated in one segment, research and development into Parkinsonian and other neurodegenerative disorders.
https://www.alteritytherapeutics.comSEC filings for ATHE on EDGAR
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 2 | 3,000,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
2 Form 4 filings on record, the earliest from Jun 23, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Julian Michael Babarczy - Director | Grant or award | Unlisted option exp 15 Jun 2031 | 2,000,000 | $0.00 | - | |
| Lawrence Bernard Gozlan - Director | Grant or award | Listed option exp 15 Jun 2031 | 1,000,000 | $0.00 | - |
ALTERITY THERAPEUTICS LTD (ATHE) had 2 insider filings in the last 90 days, with the most recent on 2026-06-23. The full record for ATHE runs to 2 Form 4 filings, the earliest from 2026-06-23. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of ATHE were filed in the last 90 days.
No insider sales of ATHE were filed in the last 90 days.
This page tracks ATHE Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add ATHE to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
